150+
Active Companies
$15B+
Total Funding Raised
50+
Pharma Partnerships
12
Public Companies

Organ-on-Chip

Emulate

Pioneer of organ-on-chip technology. Human Emulation System with multiple organ models. Founded from Wyss Institute research.

$225M Raised

CN Bio

PhysioMimix platform for liver, gut, and multi-organ models. Strong pharmaceutical partnerships.

UK-Based

TissUse

Multi-organ-chip developer with human-on-chip capabilities. Acquired by ROSEN Group.

Germany

Mimetas

OrganoPlate platform for 3D organ-on-chip models. High-throughput screening capabilities.

Netherlands

AI Drug Discovery

Recursion Pharmaceuticals

AI-powered drug discovery platform combining cellular imaging with machine learning. NASDAQ: RXRX.

Public Company

Insilico Medicine

Generative AI for drug discovery. First AI-designed drug to enter clinical trials.

$400M+ Raised

Exscientia

AI-driven drug design with multiple pharma partnerships. Multiple clinical-stage assets.

Public Company

Schrödinger

Physics-based molecular modeling platform. Powers drug discovery at major pharma.

NASDAQ: SDGR

Organoid Platforms

Organovo

3D bioprinting pioneer now focused on therapeutics. ExVive liver and kidney models.

OTC Listed

HUB Organoids

Hans Clevers-founded organoid company. Adult stem cell-derived models for drug discovery.

Netherlands

Crown Bioscience

Patient-derived tumor organoids for oncology drug development. Global CRO services.

JSR Acquisition

StemoniX

iPSC-derived screening platform. microBrain and microHeart models for neuroscience and cardiology.

Minnesota

Track Market Growth

Explore market intelligence and growth projections for human-relevant medicine technologies.

View Market Data